Following after in J&J's Taris-derived pipeline is TAR-210, an intravesical formulation of J&J's FGFR kinase inhibitor Balversa (erdafitinib), which started the phase 3 MoonRISe-1 trial in ...

J&J is developing a second Taris-derived candidate called TAR-210, an intravesical formulation of J&J's FGFR kinase inhibitor Balversa (erdafitinib), and has predicted that peak sales of the two ...

The first happened Sunday morning and left a child dead after a multi-vehicle crash around 10 a.m. on the 1100 block of NC Highway 210, south of Lillington. Responding units found the crash ...

The THOR-2 Cohort 1 study compared erdafitinib to intravesical chemotherapy in patients ... Andrea Necchi discusses the SunRISe-3 trial, a phase 3 randomized study evaluating TAR-200 plus cetrelimab, ...

Nokia 210 mobile was launched in February 2019. The phone comes with a 2.40-inch primary display offering a resolution of 240x320 pixels. The Nokia 210 runs Symbian S30+ and is powered by a 1020mAh ...

Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde ...